Bringing you the gold standard of laboratory testing to every patient’s point-of-needs.
Providing real-time PCR results in 20 minutes from sample to results, anywhere.
Enabling rapid clinical decision-making through data management and triage at the Point-of-Care testing.
Making better and faster informed decisions
Accelerate diagnostics turnaround time at a fraction of the cost
Turning informed decisions into empowering people
Diagnostics with rapid and uncompromising accuracy
Turning informed decisions into empowering people
Diagnostics with rapid and uncompromising accuracy
Providing advanced medical technology for all
Redefining healthcare for human clinical management
Laboratory Professional
Healthcare
Provider
Health System Administrator
ABOUT CREDO DIAGNOSTICS
Knowledge Empowering People
Since 2011, Credo Diagnostics has been dedicated to researching and developing revolutionary diagnostic technologies. We have created, manufactured, and commercialized accurate, rapid, and affordable molecular diagnostic solutions for point-of-care testing.
OUR REACH
Making a positive impact on the lives of billions of people around the globe
LATEST
Media News & Product Updates Keep Abreast with the Latest
Meet Us Around the World: Q4 2026 Exhibition Schedule
Q4 is shaping up to be an exciting season for Credo Diagnostics, bringing our molecular diagnostic solutions to three major international exhibitions: FASAVA, MEDICA, and
Credo Diagnostics Receives Excellence in Diagnostic Innovation at MedTech World Asia Awards 2026
A milestone in our mission to bring advanced molecular diagnostics closer to patients and veterinary care. Credo Diagnostics Biomedical received the Excellence in Diagnostic Innovation
Expo Científica CTR 2026 Highlights
From August 10 to 12, Credo Diagnostics Biomedical participated in Expo Científica CTR 2026 in Guadalajara, Mexico, bringing together professionals from across the laboratory and
Celebrating 15 Years of Innovation: Extended Warranty Program
Since 2011, Credo Diagnostics Biomedical has been dedicated to advancing molecular diagnostics through innovative Point-of-Care testing solutions. Over the past 15 years, we have worked
Expanding Companion Animal Molecular Diagnostics for Emerging Infectious Disease Challenges
Credo Diagnostics Biomedical is pleased to announce the expansion of the QubeMDx+™ veterinary molecular diagnostics portfolio with four new assays designed to support the detection
Your Partner in Molecular Diagnostics Innovation
At Credo Diagnostics Biomedical, we help partners transform innovative concepts into market-ready molecular diagnostic solutions. Backed by more than a decade of experience in molecular
Rapid Differentiation of SARS-CoV-2 Influenza and RSV at the Point-of-Care
Rapid differentiation of respiratory pathogens remains one of the key challenges in clinical diagnostics. Because SARS-CoV-2, influenza viruses, and respiratory syncytial virus (RSV) often present
Pets can’t tell us what’s wrong, but their biology can.
In vet care, speed and accuracy save lives—no time to wait or guess. QubeMDx+™ delivers fast, lab quality PCR results in 20 minutes at the
